These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 7942931

  • 21. Pharmacoepidemiology of niacin.
    Jungnickel PW, Maloley PA.
    Ann Intern Med; 1995 Mar 01; 122(5):392-3. PubMed ID: 7847654
    [No Abstract] [Full Text] [Related]

  • 22. A case for immediate-release niacin.
    Bassan M.
    Heart Lung; 2012 Mar 01; 41(1):95-8. PubMed ID: 21414665
    [Abstract] [Full Text] [Related]

  • 23. Safety and side effects of sustained-release niacin.
    Shields M, Beckmann SL.
    JAMA; 1994 Aug 17; 272(7):514; author reply 514-5. PubMed ID: 8046797
    [No Abstract] [Full Text] [Related]

  • 24. Safety and side effects of sustained-release niacin.
    Lavie CJ, Milani RV.
    JAMA; 1994 Aug 17; 272(7):513-4; author reply 514-5. PubMed ID: 8046796
    [No Abstract] [Full Text] [Related]

  • 25. Experience with crystalline niacin as the preferred drug for dyslipidemia in a specialty clinic.
    Rindone JP, Arriola OG.
    Pharmacotherapy; 1997 Aug 17; 17(6):1296-9. PubMed ID: 9399614
    [Abstract] [Full Text] [Related]

  • 26. Three new drugs for hyperlipidemia.
    Med Lett Drugs Ther; 2003 Mar 03; 45(1151):17-9. PubMed ID: 12612501
    [No Abstract] [Full Text] [Related]

  • 27. Comment: adverse-effect profile of sustained-release niacin.
    Jungnickel PW, Maloley PA.
    DICP; 1991 Sep 03; 25(9):1014-5. PubMed ID: 1949965
    [No Abstract] [Full Text] [Related]

  • 28. Adverse effects of sustained-release niacin.
    Knapp TR, Middleton RK.
    DICP; 1991 Mar 03; 25(3):253-4. PubMed ID: 2028632
    [No Abstract] [Full Text] [Related]

  • 29. Alterations in thyroid and hepatic function tests associated with preparations of sustained-release niacin.
    Drinka PJ.
    Mayo Clin Proc; 1992 Dec 03; 67(12):1206. PubMed ID: 1469935
    [No Abstract] [Full Text] [Related]

  • 30. Niacin and hepatic failure.
    Knopp RH.
    Ann Intern Med; 1989 Nov 01; 111(9):769. PubMed ID: 2802441
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Hepatic toxicity of unmodified and time-release preparations of niacin.
    Rader JI, Calvert RJ, Hathcock JN.
    Am J Med; 1992 Jan 01; 92(1):77-81. PubMed ID: 1731514
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Fulminant hepatic failure following low-dose sustained-release niacin therapy in hospital.
    Fischer DJ, Knight LL, Vestal RE.
    West J Med; 1991 Oct 01; 155(4):410-2. PubMed ID: 1771885
    [No Abstract] [Full Text] [Related]

  • 36. Acute hepatic failure associated with the use of low-dose sustained-release niacin.
    Hodis HN.
    JAMA; 1990 Jul 11; 264(2):181. PubMed ID: 2355439
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. New perspectives on the use of niacin in the treatment of lipid disorders.
    McKenney J.
    Arch Intern Med; 2004 Apr 12; 164(7):697-705. PubMed ID: 15078639
    [Abstract] [Full Text] [Related]

  • 39. One Man's Poison--Another's Fertilizer.
    Science; 1994 Mar 04; 263(5151):1220. PubMed ID: 17817420
    [No Abstract] [Full Text] [Related]

  • 40. Niacin and statin intolerable for some people.
    Tofield A.
    Eur Heart J; 2013 Sep 04; 34(33):2579. PubMed ID: 24137778
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.